BALB/c (4–6 weeks old, female) and C57Bl6/J (4 to 6 weeks old, female) mice were purchased from Charles River Laboratories (C57Bl6/J: 027; BALB/c: 028). BALB/c mice were injected (s.c.) with 2 million CT26-EpCAM cells into the right flank. When the tumor size reached 2 × 2 mm, mice were randomized and i.v. treated with 2 doses of 7.5 mg/kg SUMOi or appropriate vehicle control on days 1 and 4. Mice were euthanized 24 hours after receiving the second dose. Flow cytometric analysis of the tumors was carried out as previously described (67 (link)). C57Bl6/J mice were treated with SUMOi following the same scheme. E-myc [B6.Cg-Tg(IghMyc)22Bri/J] mice were obtained from The Jackson Laboratory (stock no. 002728). Male and female mice were examined twice a week and euthanized as soon as lymph nodes were well-palpable (5 mm diameter) or any of the approved thresholds were reached.
Free full text: Click here